Proposals for both funding opportunities will include five pages of research strategy plus a lay summary, a data management and monitoring plan, timeline, bio-sketches and budget. Reviews will be conducted online via REDCap using an NIH-style nine-point rating scale. A study section will NOT be held.
Grant Reviewer Eligibility Criteria:
- Must have Principal Investigator (PI) status as defined by The Ohio State University or Nationwide Children’s Hospital
- Must not be a current applicant
Research expertise will be considered in proposal assignments. The option to review more than one proposal is available.
Investigators are encouraged to participate in grant review, when possible, as it enhances grantsmanship and engages investigators in the latest research in their field.
If you are interested in participating as a grant reviewer, please reach out to the following contacts with your name, institution, department and area of expertise by November 1, 2024.
Clinical and Translational Science Pilot Program
Proposals routed to reviewers: Nov. 4, 2024
Reviews due: Dec. 6, 2024
Contact: Jasmine Neal, Jasmine.Neal@osumc.edu
Clinical and Translational Science Research Program
Proposals routed to reviewers: December 17, 2024
Reviews due: January 7, 2024
Contact: Jenny Grabmeier, grabmeier.3@osu.edu
Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.